Subgroup analyses further confirm that responders have a specific immunomodulatory transcriptional profile, independently of CRP levels, while the inhibition of cell-cycle-related pathways in MDD with CRP < 1 is only present in those with current MDD, that is, in non-responders and unmedicated, but not in the responders. This evidence concerns the gene CRP and major depressive disorder.